首页> 外国专利> EHRLICHIAL INVASIN FOR IMMUNIZTION, DIAGNOSIS, AND CELL DELIVERY

EHRLICHIAL INVASIN FOR IMMUNIZTION, DIAGNOSIS, AND CELL DELIVERY

机译:埃希氏菌入侵,可进行免疫,诊断和细胞递送

摘要

Disclosed are vaccines containing one or more immunogenic polypeptides derived from an EtpE protein from an Ehrlichia sp. or nucleic acid encoding these polypeptides. Also disclosed is a method for vaccinating a subject against Ehrlichia sp. that involves administering to the subject a composition comprising any of the disclosed vaccines. Also disclosed is a method for diagnosing and/or monitoring the treatment of Ehrlichiosis in a subject that comprising assaying a biological sample (e.g., blood, serum, or plasma sample) from the subject for the presence of an antibody that specifically binds an EtpE polypeptide. Also disclosed are methods for delivering a therapeutic or diagnostic agent to a cell in a subject that involves conjugating the agent, or a delivery vehicle comprising the agent, to polypeptide containing the C-terminal domain of an EtpE protein.
机译:公开了一种疫苗,该疫苗含有一种或多种源自 Ehrlichia sp的EtpE蛋白的免疫原性多肽。或编码这些多肽的核酸。还公开了一种针对埃希氏毛虫 sp接种疫苗的方法。涉及向受试者施用包含任何公开的疫苗的组合物。还公开了一种用于诊断和/或监测受试者中毛囊病的方法,该方法包括测定来自受试者的生物样品(例如血液,血清或血浆样品)中是否存在特异性结合EtpE多肽的抗体。 。还公开了将治疗剂或诊断剂递送至对象中的细胞的方法,该方法包括将所述试剂或包含所述试剂的递送载体与含有EtpE蛋白的C端结构域的多肽缀合。

著录项

  • 公开/公告号US2019134175A1

    专利类型

  • 公开/公告日2019-05-09

    原文格式PDF

  • 申请/专利权人 OHIO STATE INNOVATION FOUNDATION;

    申请/专利号US201916245904

  • 发明设计人 YASUKO RIKIHISA;DIPU MOHAN-KUMAR;

    申请日2019-01-11

  • 分类号A61K39/02;A61K47/64;G01N33/569;A61K39/385;G01N33/68;C07K14/29;

  • 国家 US

  • 入库时间 2022-08-21 12:05:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号